SparlingPF.Antibiotic resistance in the gonococcus. In: RobertsRB, ed. The gonococcus. New York: John Wiley, 1977:111–35.
2.
SparlingPFSoxTEMohammedWGuymonLF.Antibiotic resistance in the gonococcus: Diverse mechanisms of coping with a hostile environment. In: BrooksGFGotschlichECHolmesKK, eds. Immunobiology of Neisseria gonorrhoeae. Washington, DC: American Society for Microbiology, 1978;44–52.
TapsallJWPhillipsEAMorrisLM.Chromosomally mediated intrinsic resistance to penicillin of penicillinase producing strains of Neisseria gonorrhoeae isolated in Sydney: guide to treatment with Augmentin. Genitourin Med1987;63:305–8.
5.
MorseSAJohnsonRSBiddleWJRobertsMC.High-level tetracycline resistance in Neisseria gonorrhoeae is due to acquisition of the streptococcal tetM determinant. Antimicrob Agents Chemother1986;30:664–70.
6.
PercivalAHartCA.Rationale for antimicrobial therapy of infections caused by multiply resistant Neisseria gonorrhoeae. In: BrooksGFGotschlichECHolmesKK, eds. Immunobiology of Neisseria gonorrhoeae. Washington, DC: American Society for Microbiology, 1978:80–5.
7.
ManessMJFosterGCSparlingPF.Ribosomal resistance to streptomycin and spectinomycin in Neisseria gonorrhoeae. J Bacteriol1974;120:1293–9.
8.
PhilpotCRTapsallJW.Single-dose antibiotic therapy for the treatment of uncomplicated anogenital gonorrhoea. Med J Aust1987;146:254–6.
9.
SchwarczSKZenilmanJMSchnellDNational surveillance of resistance in Neisseria gonorrhoeae. JAMA1990;264:1413–7.
10.
Australian gonococcal surveillance programme. The incidence of gonorrhoea and the antibiotic sensitivity of gonococci in Australia, 1981–1991. Genitourin Med1993;69:364–9.
11.
Anonymous. Global surveillance network for gonococcal antimicrobial susceptibility. WHO Bulletin1992;70:137–8.
12.
Anonymous. World Health Organization Western Pacific Region gonococcal surveillance, 1992 annual report. Comm Dis Intell1994;18:61–3.
13.
Anonymous. World Health Organization Western Pacific Region gonococcal surveillance, 1993 annual report. Comm Dis Intell1994;18:307–10.
TapsallJWPhillipsEA.The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to Cefpodoxime and other antibiotics used to treat gonorrhoea. Pathology (In press).
18.
TurnerAJephcottAEHajiTCGuptaPC.Ciprofloxacin resistant Neisseria gonorrhoeae in the UK. Genitourin Med1990;66:43.
19.
CorkillJEPercivalALindM.Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains. J Antimicrob Chemother1991;26:601–4.
20.
TapsallJWShultzTRLovettRMunroR.Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea. Med J Aust1992;156:143.
21.
Van DyckERossauRDuhamelMAntimicrobial susceptibility of Neisseria gonorrhoeae in Zaire: high level plasmid-mediated tetracycline resistance in Central Africa. Genitourin Med1992;68:111–16.
22.
HandfieldHHDaluZAMartinDHMulticenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhoea. Sex Transm Dis1994;21:107–11.
23.
BrownSBiddleJWarnissornTPanikabutraKTraisupaA.Antimicrobial resistance in Neisseria gonorrhoeae in Bangkok: is single-drug treatment passé?Lancet1982;ii:1366–8.
24.
BirleyHMcDonaldPCareyP.High level ciprofloxacin resistance in Neisseria gonorrhoea. Genitourin Med1994;70:292–3.